APRIL 30, 2025 News Release PNNL Hosts Inaugural Conference on Predictive Phenomics PNNL is hosting a scientific conference focused directly on understanding and predicting the collection of an organism’s traits. ( Read More )
APRIL 8, 2025 News Release Disturbed Sleep Cycle Propels Cyanobacteria Into Surprising Burst of Productivity Circadian rhythms of blue-green microbes offer new window into predictive phenomics—how to predict and control the traits of an organism. ( Read More )
FEBRUARY 13, 2025 News Release Beyond DNA: How Environments Influence Biology to Make Things Happen This week at AAAS, PNNL scientists discuss phenomics and the factors that influence DNA instructions to bring about the world around us. ( Read More )
OCTOBER 1, 2024 Research Highlight PeakQC Software Advances Quality Control for Omics-Agnostic Mass Spectrometry A cross-institutional team of scientists developed PeakQC, a new software tool for automated quality control of mass spectrometry data. ( Read More )
AUGUST 9, 2024 Staff Accomplishment PNNL Lab Fellow Recognized for Contributions to Mass Spectrometry Ljiljana Paša-Tolić, a PNNL fellow, is the recipient of the 2024 International Mass Spectrometry Foundation’s Jochen Franzen Award. ( Read More )
MAY 1, 2024 News Release When Working Out, Males Are Programmed to Burn More Fat, while Females Recycle It—at Least in Rats Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes. ( Read More )
MARCH 1, 2024 News Release PNNL Scientists Help Pinpoint Molecular Switch Active in Type-1 Diabetes Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes. ( Read More )
FEBRUARY 2, 2024 News Release Proteins Suggest a Path to Reduce Drug Resistance in a Form of Cancer Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed. ( Read More )
FEBRUARY 21, 2023 Research Highlight Artificial Intelligence Drives Design, Discovery, and Testing of Targeted Therapeutics against SARS-CoV-2 Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities. ( Read More )